Family-owned drug factories in India erode US generic pricesPost published:August 31, 2017Post category:Industry NewsExpansion by Indian pharma firms is boosting competition in the US, where mergers and pricing wars among drugmakers had already been driving down cost of generics Source: Livemint.com (http://www.livemint.com/rss/industry)Read more articles Previous PostRBI mandates 50% provisioning for NCLT cases Next PostHow Nandan Nilekani returned to Infosys You Might Also Like Tata Motors showrooms to get a facelift in bid to woo younger customers July 17, 2017 Ford to Stop Passenger Vehicle Manufacturing in Russia, Closing 3 Factories March 27, 2019 Yokogawa introduces R2 FlowNavigator software January 7, 2019